This article provides a comprehensive, evidence-based analysis of the long-term safety profiles of bioidentical and synthetic hormones used in menopausal hormone therapy.
This article synthesizes current advances in the development and validation of novel biomarkers for predicting long-term response to hormone therapy across therapeutic areas, including oncology and endocrinology.
This article provides a comprehensive, head-to-head comparison of different progestins and their association with long-term breast cancer risk, tailored for researchers, scientists, and drug development professionals.
This article synthesizes current evidence on the physiological challenge of weight gain and metabolic adaptation during extended hormone therapy, with a focus on menopausal hormone therapy (MHT).
This article provides a comprehensive analysis of strategies for ensuring long-term endometrial protection in perimenopausal women undergoing hormone therapy.
This article provides a comprehensive analysis of the critical challenge of variability in hormone absorption and metabolism over extended treatment periods.
Non-adherence to prescribed treatments affects 30-50% of pediatric patients with chronic endocrine conditions, leading to suboptimal growth, increased complications, and significant avoidable healthcare costs.
This comprehensive review addresses the critical challenge of assessing hormone receptor sensitivity dynamics throughout extended cancer treatment regimens.
This article provides a detailed methodological framework for researchers and drug development professionals to design robust, long-term studies evaluating body composition changes during hormone optimization.
This article provides a comprehensive analysis of longitudinal biomarker monitoring strategies for pediatric hormone therapy, addressing the unique challenges and opportunities in this population.